Valneva SE
VALN- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001836564
No open-market purchases or sales by Valneva SE insiders were filed in the last 90 days; 20 institutions reported holding it in 13F filings for Q2 2026, worth $19.8M in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding Valneva SE changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 9 | 11 | +2 |
| Shares | 61.9K | 434.2K | +372.2K (+601.2%) |
| Value | $1.40M | $4.36M | +$2.96M (+211.2%) |
New holders (2)
Institutions that held Valneva SE at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| General American Investors Co Inc | 375,000 | $3.77M | 0.39% |
| Ronald Blue Trust, Inc. | 10 | $0 | 0.00% |
Sold out (0)
Institutions that held Valneva SE at the end of Q2 2022 and filed for Q3 2022 without it.
None.